MorNuCo's program of technology development is focused on innovative solutions to better health and well-being based on a family of cell-surface ECTO-NOX (ENOX) proteins with therapeutic and diagnostic potential for the principle disorders of aging, with emphasis on cancer, as well as cardiovascular and neurodegenerative diseases. MorNuCo's approach is to detect early before the disease progresses and to begin treatment well in advance of life-threatening symptoms.
View Top Employees from MorNuCo, Inc.| Website | http://oncoblotlabs.com |
| Revenue | $3 million |
| Employees | 3 (3 on RocketReach) |
| Founded | 2011 |
| Address | 1201 Cumberland Avenue Suite B, West Lafayette, Indiana 47906, US |
| Phone | (765) 464-1583 |
| Industry | Biotechnology Research, Software General, Cancer Confirmation, Software, Early Cancer Intervention, Early Cancer Detection |
| SIC | SIC Code 80 Companies, SIC Code 807 Companies |
| NAICS | NAICS Code 6215 Companies, NAICS Code 621 Companies, NAICS Code 62 Companies, NAICS Code 62151 Companies |
Looking for a particular MorNuCo, Inc. employee's phone or email?
MorNuCo, Inc. Questions
The MorNuCo, Inc. annual revenue was $3 million in 2024.
PHD-Candidate Mohamad Zaroura is the Commercial Vice President of MorNuCo, Inc..
3 people are employed at MorNuCo, Inc..
MorNuCo, Inc. is based in West Lafayette, Indiana.
The NAICS codes for MorNuCo, Inc. are [6215, 621, 62, 62151].
The SIC codes for MorNuCo, Inc. are [80, 807].
Top MorNuCo, Inc. Employees
-
ViewPHD-Candidate Mohamad Zaroura
Commercial Vice President at MorNuCo, Inc.
West Lafayette, IN, US -
33
-
1
Related Companies
